Sanofi Healthcare tracks allergy relief from wearable devices

In the experiment, 80 allergy sufferers and 80 non-sufferers wore the device.
In the experiment, 80 allergy sufferers and 80 non-sufferers wore the device. | File photo
Sanofi Healthcare, the company behind Xyzal Allergy 24HR, recently announced the results of an allergy-related social experiment involving 160 participants who wore wearable devices for 30 days to track sleep and activity.
In the experiment, 80 allergy sufferers and 80 non-sufferers wore the device; the results found that allergy symptoms can impact various elements of suffers’ lives – both while they sleep and while they are awake.
"Many allergy sufferers have gotten so used to their symptoms that they don't even realize how significantly they may be impacting their day-to-day lives, including everything from their sleep at night to their productivity during the day. But the results of this social experiment should serve as a wake-up call," Dr. Neeta Ogden said in Sanofi’s press release. "If your allergy symptoms aren't under control, it's time to educate yourself about both your triggers and your treatment options, so you can find relief that doesn't rest and enjoy the spring season."
Specific findings from the experiment included the fact that allergy sufferers had harder times falling asleep and staying awake than non-sufferer counterparts and that allergy sufferers were less rested and less physically active than non-sufferers as they moved throughout their days.
Want to get notified whenever we write about Sanofi US ?
Next time we write about Sanofi US, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Sanofi US 55 Corporate Dr Bridgewater, NJ 08807